Quercetin, rutin, and their combinations modulate penile phosphodiesterase-5′, arginase, acetylcholinesterase, and angiotensin-I-converting enzyme activities: a comparative study

被引:12
作者
Adefegha S.A. [1 ]
Oboh G. [1 ]
Fakunle B. [1 ]
Oyeleye S.I. [1 ,2 ]
Olasehinde T.A. [3 ,4 ]
机构
[1] Functional Foods and Nutraceuticals Unit, Department of Biochemistry, Federal University of Technology Akure, PMB 704, Akure, Ondo State
[2] Department of Biomedical Technology, Federal University of Technology Akure, PMB 704, Akure, Ondo State
[3] Department of Biochemistry and Microbiology, University of Fort Hare, Alice, 5700, Eastern Cape
[4] Nutrition and Toxicology Division, Food Technology Department, Federal Institute of Industrial Research, Oshodi, PMB 21023, Lagos
关键词
Erectile dysfunction; Phosphodiesterase-5′; Quercetin; Rutin;
D O I
10.1007/s00580-018-2664-y
中图分类号
学科分类号
摘要
This study demonstrates the effects of rutin and quercetin and their various combinations on phosphodiesterase-5 (PDE-5), arginase, acetylcholinesterase (AChE), and angiotensin-I-converting enzyme (ACE) activities in vitro. The effects of the flavonoids against Fe2+- and sodium nitroprusside (SNP)-induced lipid peroxidation in rats’ corpus cavernosum tissues were also investigated. Quercetin and rutin were dissolved in dimethylsulfoxide (DMSO) to a final concentration of 1 mM each. Thereafter, their combinations (50% quercetin + 50% rutin [Q1:R1]; 75% quercetin + 25% rutin [Q3:R1]; 25% quercetin + 75% rutin [Q1:R3]) were prepared. Our findings revealed that both flavonoids inhibited PDE-5, arginase, AChE, and ACE activities. Rutin exhibited significantly higher inhibitory effects on PDE-5, AChE, and ACE activities compared to quercetin. Considering the combinations, Q1:R3 was more potent compared to Q1:R1 and Q3:R1. Both flavonoids inhibited Fe2+- and SNP-induced lipid peroxidation in rat’s corpus cavernosa tissues. Rutin also showed higher inhibitory effects on Fe- and SNP-induced lipid peroxidation. Similarly, the combinatorial effects of the flavonoids revealed that Q1:R3 significantly inhibited malondialdehyde (MDA) production compared to Q1:R1 and Q3:R1. In conclusion, our findings suggest that the combination of quercetin and rutin is more potent than their individual effect. © 2018, Springer-Verlag London Ltd., part of Springer Nature.
引用
收藏
页码:773 / 780
页数:7
相关论文
共 43 条
[1]  
Ademosun A.O., Oboh G., Bello F., Ayeni P.O., Antioxidative properties and effect of quercetin and its glycosylated form (rutin) on acetylcholinesterase and butyrylcholinesterase activities, J Evid Based Complementary Altern Med, 21, pp. 11-15, (2015)
[2]  
Agarwal A., Nandipati K.C., Sharma R.K., Zippe C.D., Raina R., Role of oxidative stress in the pathophysiological mechanism of erectile dysfunction, J Androl, 7, 3, pp. 335-346, (2006)
[3]  
Akomolafe S.F., Oboh G., Oyeleye S.I., Boligon A.A., Aqueous flavonoids from Ficuscapensis leaves inhibits key enzymes linked to erectile dysfunction and prevent oxidative stress in rats’ penile tissue, NFS J, 4, pp. 15-21, (2016)
[4]  
Anand P., Singh B., Flavonoids as lead compounds modulating the enzyme targets in Alzheimer’s disease, Med Chem Res, 22, pp. 3061-3075, (2013)
[5]  
Andersson K.E., Mechanisms of penile erection and basis for pharmacological treatment of erectile dysfunction, Pharmacol Rev, 63, pp. 811-859, (2011)
[6]  
Belle E.M., Duret L., Galtier N., Eyre-Walker A., The decline of isochores in mammals: an assessment of the GC content variation along the mammalian phylogeny, J Mol Evol, 58, pp. 653-660, (2004)
[7]  
Corbin J.D., Mechanisms of action of PDE5 inhibition in erectile dysfunction, Int J Impot Res, 16, pp. 4-7, (2004)
[8]  
Cushman D.W., Cheung H.S., Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung, Biochem Pharm, 20, pp. 1637-1648, (1971)
[9]  
Da Silva E.R., Maquiaveli C.D., Magalhaes P.P., The leishmanicidalflavonols quercetin and quercitrin target Leishmania (Leishmania) amazonensis arginase, Exp Parasitol, 130, pp. 183-188, (2012)
[10]  
Ferrario C.M., Levy P., Sexual dysfunction in patients with hypertension: implications for therapy, J Clin Hypertens, 4, pp. 424-432, (2002)